| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1989PNAS...86.7437R |
| P356 | DOI | 10.1073/PNAS.86.19.7437 |
| P932 | PMC publication ID | 298079 |
| P698 | PubMed publication ID | 2477841 |
| P5875 | ResearchGate publication ID | 20677979 |
| P2093 | author name string | Alkan SS | |
| Chiquet-Ehrismann R | |||
| Rüegg CR | |||
| P2860 | cites work | Accessory molecules in T lymphocyte activation | Q39594416 |
| Fibronectin mediates attachment of chicken myoblasts to a gelatin-coated substratum | Q39665706 | ||
| The T cell receptor | Q39682077 | ||
| The J1 glycoprotein--a novel nervous system cell adhesion molecule of the L2/HNK-1 family | Q41242730 | ||
| Lymphocyte migration into three-dimensional collagen matrices: a quantitative study | Q41395446 | ||
| Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme | Q41540765 | ||
| Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity | Q42152584 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Immunochemical and biochemical characterization of a glioma-associated extracellular matrix glycoprotein | Q44167989 | ||
| ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells | Q44528252 | ||
| Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis | Q46128262 | ||
| Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. | Q55486981 | ||
| Regulatory properties of LFA-1 α and β chains in human T-lymphocyte activation | Q58986686 | ||
| Antigen-specific interaction between T and B cells | Q59063745 | ||
| A six-armed oligomer isolated from cell surface fibronectin preparations | Q59099035 | ||
| Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) | Q68202545 | ||
| Tenascin interferes with fibronectin action | Q69025836 | ||
| Mitogen stimulation promotes human T lymphocyte adhesion to fibronectin | Q70043646 | ||
| Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation | Q70358907 | ||
| Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation | Q70562670 | ||
| How does the extracellular matrix direct gene expression? | Q71846181 | ||
| Interaction between CD4 and class II MHC molecules mediates cell adhesion | Q24339626 | ||
| The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis | Q24610109 | ||
| The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3 | Q28285374 | ||
| Integrins: a family of cell surface receptors | Q28288125 | ||
| Cell-cell adhesion mediated by CD8 and MHC class I molecules | Q34171411 | ||
| Tenascin is a stromal marker for epithelial malignancy in the mammary gland | Q34636488 | ||
| The structure of the CD4 and CD8 genes | Q34685548 | ||
| T-lymphocyte differentiation and the extracellular matrix: identification of a thymocyte subset that attaches specifically to fibronectin | Q35600528 | ||
| Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis | Q36209755 | ||
| Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits | Q36209892 | ||
| Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro | Q36217281 | ||
| Induction of tenascin in healing wounds | Q36220912 | ||
| Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction | Q37556924 | ||
| Extracellular matrices and cell adhesion. | Q38155815 | ||
| Molecular signaling mechanisms in T-lymphocyte activation pathways: a review and future prospects | Q38177074 | ||
| Discontinuous density gradient separation of human minonuclear leucocytes using percoll® as gradient medium | Q39288243 | ||
| Adhesive protein receptors on hematopoietic cells | Q39338085 | ||
| LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes | Q39592883 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular matrix | Q193825 |
| P304 | page(s) | 7437-7441 | |
| P577 | publication date | 1989-10-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Tenascin, an extracellular matrix protein, exerts immunomodulatory activities | |
| P478 | volume | 86 |
| Q59922049 | 1,25-Dihydroxyvitamin D3 inhibits tenascin-C expression in mammary epithelial cells |
| Q35927432 | A brief overview of the pathogenesis of scleroderma (systemic sclerosis) |
| Q34961648 | A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices |
| Q73449236 | An alkali-soluble factor present in normal brain tissue inhibits antigen-specific lymphocyte proliferation |
| Q44460702 | An immunohistochemical study of the 'snowbank' in a case of pars planiti |
| Q40548687 | Biopathologic features of Hodgkin's disease |
| Q46017590 | Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation. |
| Q36786956 | Cell Adhesion Proteins in Oral Biology |
| Q88316825 | Cell adhesion protein fibulin-7 and its C-terminal fragment negatively regulate monocyte and macrophage migration and functions in vitro and in vivo |
| Q38005392 | Cell-matrix interactions during tumor invasion |
| Q35654907 | Clinical comments and a pathophysiological discussion of scleroderma |
| Q72096010 | Comparative Analysis of the Expression of Tenascin and Established Prognostic Factors in Human Breast Cancer |
| Q35833492 | Constitutive expression of tenascin in T-dependent zones of human lymphoid tissues |
| Q40459398 | Correlation of fibrinogen-like protein 2 with progression of acute pancreatitis in rats. |
| Q36529819 | Cytokines in context |
| Q38173348 | Danger signals in the initiation of the inflammatory response after myocardial infarction |
| Q35937046 | Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice |
| Q71736495 | Differential expression of tenascin in the skin during hapten-induced dermatitis |
| Q36383276 | Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts |
| Q41658996 | Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development |
| Q81628736 | Expression of growth factors in the conjunctiva from patients with active trachoma |
| Q39579713 | Expression of tenascin in lymphocytic autoimmune thyroiditis |
| Q71459145 | Extracellular matrix and beta 1 integrin expression in nodal and extranodal T-cell lymphomas |
| Q71565300 | Extracellular matrix proteins and integrin receptors in reactive and non-reactive lymph nodes |
| Q39809934 | Extracellular matrix proteins, regulators of T-cell functions in healthy and diseased individuals. |
| Q51983999 | Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice. |
| Q44956966 | Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymer implants: study of the expression of tenascin and cellular fibronectin |
| Q41658744 | Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin |
| Q42446380 | Immuno-histochemical evaluation of conjunctival remodelling in vernal keratoconjunctivitis |
| Q38608340 | Immunological hallmarks of stromal cells in the tumour microenvironment |
| Q36293594 | Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity |
| Q40966899 | Inhibition of tenascin-C expression in mammary epithelial cells by thyroid hormone. |
| Q49553693 | Internal Affairs: Tenascin-C as a Clinically Relevant, Endogenous Driver of Innate Immunity |
| Q54967966 | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. |
| Q33880848 | Isolation and characterisation of a hyaluronan binding protein, hyaluronectin, from human placenta and its colocalisation with hyaluronan. |
| Q72084845 | Localization of tenascin in human skin wounds--an immunohistochemical study |
| Q33536274 | Lymphopoiesis and matrix glycoprotein SC1/ECM2. |
| Q35186471 | Mammary gland involution as an immunotherapeutic target for postpartum breast cancer. |
| Q36249015 | Mcs5c: a mammary carcinoma susceptibility locus located in a gene desert that associates with tenascin C expression. |
| Q41156955 | Mechanisms of tubulointerstitial fibrosis |
| Q77146570 | Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen |
| Q35809927 | Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis |
| Q41834186 | PDGF and TGF-β promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice |
| Q28080245 | Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation |
| Q34093259 | Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix |
| Q41050861 | T-lymphocyte interactions with endothelium and extracellular matrix. |
| Q55476202 | Tenascin expression patterns and cells of monocyte lineage: relationship in human gliomas. |
| Q36664798 | Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: Biologic and pathologic implications |
| Q42953169 | Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment |
| Q36274122 | Tenascin supports lymphocyte rolling |
| Q43095351 | Tenascin-C expression in normal, inflamed, and scarred human corneas |
| Q42483473 | Tenascin-C expression in papulosquamous disorders other than psoriasis in pediatric patients: an epiphenomenon? |
| Q46961819 | Tenascin-C in chronic canine hepatitis: immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage, and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3+ cells |
| Q40356297 | Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma. |
| Q24310127 | Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B |
| Q38069948 | Tenascins and inflammation in disorders of the nervous system. |
| Q40412690 | The extracellular matrix of the hematopoietic microenvironment |
| Q36908735 | The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation |
| Q44621270 | The human placenta: a model for tenascin expression |
| Q57673817 | The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis |
| Q39280466 | The role of tenascin-C in tissue injury and tumorigenesis |
| Q64248984 | Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases |
| Q42233374 | Zeolite-Containing Mixture Supplementation Ameliorated Dextran Sodium Sulfate-Induced Colitis in Mice by Suppressing the Inflammatory Bowel Disease Pathway and Improving Apoptosis in Colon Mucosa |
| Q73237523 | alpha5 integrin distribution and TGFbeta1 gene expression in supraglottic carcinoma: their role in neoplastic local invasion and metastasis |
Search more.